https://www.selleckchem.com/products/xmu-mp-1.html
001). Furthermore, patients with high TIM-3 expression had significantly lower complete remission rates following induction chemotherapy compared with those with low TIM-3 expression (P=0.004). High TIM-3 expression was significantly associated with lower overall survival rates during the 1-year follow-up (P=0.001). Taken together, the results of the present study suggest that TIM-3 may act as a biomarker of a poor prognosis in patients with AML, and be used as a therapeutic target.Hepatocellular carcinoma (HCC) is a life-threatening c
Me gusta
No me gusta
Comentario
Compartir
